Home > Category > Signaling Pathways > Proteases > HIV Protease > Lenacapavir |GS-6207

Lenacapavir |GS-6207

ChemLeader 98+%

Catalog No：CL2746 CAS No.：2189684-44-2 MDLNo： Formula：C39H32ClF10N7O5S2 MW：968.28

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Lenacapavir \|GS-6207
CAS	2189684-44-2
Formula	C39H32ClF10N7O5S2
MW	968.28
Appearance	White to light yellow powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Lenacapavir (GS-6207) is a novel, first-in-class,long-acting and highly potent HIV-1 capsid inhibitor approved in EU on August 22, 2022 to treat HIV patients infected with multidrug-resistant virus and as a twice-yearly injectable for pre-exposure prophylaxis.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL2746

Lenacapavir |GS-6207

2189684-44-2 98+%